Your browser doesn't support javascript.
Continued HPV vaccination in the face of unexpected challenges: A commentary on the rationale for an extended interval two-dose schedule.
Whitworth, Hilary S; Schiller, John; Markowitz, Lauri E; Jit, Mark; Brisson, Marc; Simpson, Evan; Watson-Jones, Deborah.
  • Whitworth HS; Clinical Research Department, London School of Hygiene and Tropical Medicine, London, UK. Electronic address: hilary.whitworth@lshtm.ac.uk.
  • Schiller J; National Cancer Institute, National Institutes of Health, Maryland, USA.
  • Markowitz LE; National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, USA.
  • Jit M; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.
  • Brisson M; Centre de recherche du CHU de Québec and Department of Social and Preventive Medicine, Université Laval, Quebec, QC, Canada.
  • Simpson E; Center for Vaccine Innovation and Access, PATH, Seattle, USA.
  • Watson-Jones D; Clinical Research Department, London School of Hygiene and Tropical Medicine, London, UK.
Vaccine ; 39(6): 871-875, 2021 02 05.
Article in English | MEDLINE | ID: covidwho-1044698
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Uterine Cervical Neoplasms / Papillomavirus Infections / Papillomavirus Vaccines Topics: Vaccines Limits: Female / Humans Language: English Journal: Vaccine Year: 2021 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Uterine Cervical Neoplasms / Papillomavirus Infections / Papillomavirus Vaccines Topics: Vaccines Limits: Female / Humans Language: English Journal: Vaccine Year: 2021 Document Type: Article